PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Bio-Synthesis, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bio-Synthesis, Inc. Launches Peptide Library Generation Software - Bio-Synthesis has launched a new software intended to help with epitope identification and sequence optimization by using six powerful peptide libraries
Bio-Synthesis, Inc. Launches Peptide Library Generation Software

 

NewswireToday - /newswire/ - Lewisville, TX, United States, 2009/09/02 - Bio-Synthesis has launched a new software intended to help with epitope identification and sequence optimization by using six powerful peptide libraries.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Long established custom biomedical manufacturer, Bio-Synthesis, Inc., has launched the Peptide Library Generation Tools Software, a versatile platform complete with six powerful screening tools, each designed to help with epitope identification and sequence optimization to best fit the customer’s current/future applications. The tools include Overlapping Peptide Library, Alanine Scanning Library, Positional Library, Truncation Library, Random Library and Scrambled Library.

Each library has a different ability to assist and evaluate sequences based on the researchers specific needs. The overlapping library breaks down the original protein or peptide into fragments of equal length which allows the researcher to see which segments of the original protein or peptide yield the highest activity. The alanine scanning library is extremely useful in identifying which amino acids are essential to the peptide’s function by indicating the level of importance associated with each replaced amino acid.

The positional library is used when a position or positions in a peptide sequence are each replaced with different amino acids in order to determine the preferred amino acid residues at these positions. The truncation library is extremely useful for determining the minimum length required for optimum peptide activity. The goal of the random library protocol is to substitute randomly selected amino acids with a mixture of all 20 amino acids. The scrambled library is used to examine all possible combinations of the same amino acids from the original sequence.

As technology advances, screening tools such as these libraries prove to be invaluable to research, with each library having its own ability to quickly and efficiently examine and screen a sequence for epitope identification and sequence verification. The sequences generated through the Peptide Library Generation Tools Software can then be passed to Bio-Synthesis, Inc. for custom synthesis, a feature adding to the comprehensive approach to support the growth of more efficient, cost-effective, and focused research.

About Bio-Synthesis, Inc.
Bio-Synthesis, Inc. (biosyn.com), headquartered in Lewisville, Texas, is a leading biomedical manufacturer of custom peptide synthesis, custom antibodies, Custom PNA Synthesis, custom DNA, RNA synthesis, HLA/DNA typing, organic synthesis and a diverse number of bimolecular products for the biomedical/life science community worldwide since 1984. Their staff of highly experienced and qualified chemists, biologists and immunologists has reliably and consistently provided products and services to large pharmaceuticals and universities across the country that meet the most demanding requirements for quality, turnaround and expert technical support.

For more information, please call 1-800-227-0627.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bio-Synthesis, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Bio-Synthesis, Inc. Launches Peptide Library Generation Software

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Angela Ragan - BioSyn.com 
972-420-8505 biosyn[.]biosyn.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Synthesis, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bio-Synthesis, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)